Vanguard Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.3M Buy
6,634,751
+26,243
+0.4% +$110K ﹤0.01% 2249
2026
Q2
$27.8M Buy
6,608,508
+511,054
+8% +$1.97M ﹤0.01% 2275
2026
Q1
$21.4M Buy
+6,097,454
New +$25M ﹤0.01% 2303

Other funds holding IRWD

Vanguard Capital Management's IRWD Position: Q3 2026 in Review

Vanguard Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 0.4% in Q3 2026, buying an estimated $110K and bringing the position to 6,634,751 shares worth $26.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Vanguard Capital Management first reported a position in IRWD in Q1 2026 and has held it in 3 quarters since. The position peaked at $27.8M in Q2 2026. 233 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Vanguard Capital Management held 6,634,751 shares of Ironwood Pharmaceuticals worth $26.3M as of Q3 2026.
  • Vanguard Capital Management bought 26,243 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $110K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2249 holding.
  • Vanguard Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Ironwood Pharmaceuticals position peaked at $27.8M in Q2 2026.
  • 233 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.